arrow
A

Agata Tymińska

medical university of warsaw
H指数:21
被引数:1,410

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical characteristics associated with failure to achieve a prespecified guideline-directed medical therapy target at discharge in patients with HFrEF undergoing scheduled hospitalization: a secondary analysis of the HEROES study

在计划住院的HFrEF患者中,与出院时未达到预设指南指导药物治疗目标相关的临床特征:HEROES研究的二次分析

2026-08-300
OA
Association Between Heart Failure Etiology and All-Cause Mortality with Sex-Specific Considerations: Insights from the HEROES Registry

心力衰竭病因与全因死亡率之间的关联及性别特异性考量:来自HEROES注册研究的见解

2026-06-190
OA
Health-related quality of life and mortality in patients with atrial fibrillation and the whole spectrum of heart failure: Insights from the Heart Failure Observational Study (HEROES)

房颤和心力衰竭全谱系患者的生活质量与死亡率:心力衰竭观察性研究(HEROES)的启示

2026-01-010
PRE
Integrated Care in Patients with Atrial Fibrillation and Optimal Medical Treatment for Heart Failure: Results from the Heart failuRe ObsErvational Study (HEROES)

心房颤动患者中的综合护理和心力衰竭的最佳药物治疗:来自心力衰竭观察研究(HEROES)的结果

2025-11-240
OAAI
Reasons for inertia of treatment with flozins across the whole spectrum of heart failure in Poland based on the Heart Failure Observational Study of the Polish Cardiac Society (HEROES)

基于波兰心脏病学会心力衰竭观察研究(HEROES)的波兰心力衰竭全谱系中flozins治疗惰性的原因

2025-09-290
OAAI
Development of PDGF-BB-derived biomaterial: An ‘artificial’ concatemeric protein for regenerative applications

PDGF-BB衍生生物材料的发展:一种用于再生应用的‘人工’串联蛋白

2025-06-160
PRE
Identifying differentiation markers between dermal fibroblasts and adipose-derived mesenchymal stromal cells (AD-MSCs) in human visceral and subcutaneous tissues using single-cell transcriptomics
2025-02-110
OAAI
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
2023-06-016
OA
Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry

房颤患者的心力衰竭:来自EORP-AF全球长期注册研究波兰分中心的见解

2022-11-224
OA
Fifteen-Year Differences in Indications for Cardiac Resynchronization Therapy in International Guidelines-Insights from the Heart Failure Registries of the European Society of Cardiology

国际指南中心脏再同步治疗适应症的15年差异-来自欧洲心脏病学会心力衰竭注册中心的见解

2022-06-062
OAAI